Therapeutics: Human cytomegalovirus (CMV) type 2 membrane protein (UL50); CMV type 3 membrane protein (UL53)

Infectious disease

INDICATION: Cytomegalovirus (CMV)

In vitro studies suggest disrupting UL50-UL53 binding could help treat CMV

Read the full 147 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE